Form 4 for WST West Pharmaceutical Services
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001127602-24-006414 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-22 | 2024-02-20 | WST | Winters Chad | VP, CAO | A - Grant | $0.00 | +179 | 1,449 | +14% | $0 |
| D | 2024-02-22 | 2024-02-20 | WST | Winters Chad | VP, CAO | A - Grant | $0.00 | +1,020 | 1,020 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 179 | $0.00 | 1,448.70 | D | — | — | (F1) 2021 PSUs (PP20) award vesting net of taxes withheld. |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-02-20 | A | A | 1,020 | $0.00 | 1,020 | D | $350.18 · 2025-02-20 to 2034-02-20 | 1,020 Stock Options (Right to Buy) | (F2) This grant vests in four equal installments beginning on February 20, 2025. |